Gedeon Richter PLC (FRA:RIG2)

Germany flag Germany · Delayed Price · Currency is EUR
25.00
0.00 (0.00%)
Last updated: Dec 5, 2025, 8:03 AM CET
-1.81%
Market Cap 4.60B
Revenue (ttm) 2.31B
Net Income (ttm) 582.91M
Shares Out n/a
EPS (ttm) 3.18
PE Ratio 7.90
Forward PE 6.40
Dividend 1.26 (5.03%)
Ex-Dividend Date Jun 3, 2025
Volume n/a
Average Volume 22
Open 25.00
Previous Close 25.00
Day's Range 25.00 - 25.00
52-Week Range 22.94 - 27.48
Beta n/a
RSI 41.72
Earnings Date Feb 8, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic ... [Read more]

Industry Pharmaceutical Preparations
Founded 1901
Employees 10,943
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RIG2
Full Company Profile

Financial Performance

In 2024, Gedeon Richter's revenue was 857.55 billion, an increase of 6.51% compared to the previous year's 805.16 billion. Earnings were 239.24 billion, an increase of 50.61%.

Financial numbers in HUF Financial Statements

News

There is no news available yet.